Activist 13D/13G Filings - Rubric Capital Management LP

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, 2, ...5, 6, Next
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2024-11-13
4:30 pm
Purchase
13GArcutis Biotherapeutics Inc.
ARQT
Rubric Capital Management LP10,966,672
9.380%
4,322,142increase
(+65.05%)
View
2024-11-13
4:30 pm
Purchase
13GCoherus BioSciences Inc.
CHRS
Rubric Capital Management LP10,400,000
9.030%
10,400,000increase
(New Position)
View
2024-11-13
4:30 pm
Purchase
13GKiniksa Pharmaceuticals International plc
KNSA
Rubric Capital Management LP2,419,103
5.960%
2,419,103increase
(New Position)
View
2024-11-13
4:30 pm
Purchase
13GSCHRODINGER INC
SDGR
Rubric Capital Management LP3,685,503
5.790%
3,685,503increase
(New Position)
View
2024-11-13
4:30 pm
Purchase
13GSeaport Entertainment Group Inc.
SEG
Rubric Capital Management LP276,942
5.020%
276,942increase
(New Position)
View
2024-11-13
4:30 pm
Sale
13GSUTRO BIOPHARMA INC.
STRO
Rubric Capital Management LP0
0.000%
-3,344,810decrease
(Position Closed)
View
2024-11-13
4:30 pm
Purchase
13GTalen Energy Corp
TLN
Rubric Capital Management LP11,368,614
22.290%
11,368,614increase
(New Position)
View
2024-11-13
4:30 pm
Purchase
13GADAPTIVE BIOTECHNOLOGIES CORP
ADPT
Rubric Capital Management LP14,400,000
9.760%
14,400,000increase
(New Position)
View
2024-11-13
4:30 pm
Sale
13GANI PHARMACEUTICALS INC
ANIP
Rubric Capital Management LP56,671
0.270%
-1,068,329decrease
(-94.96%)
View
2024-11-13
4:30 pm
Sale
13GBGC GROUP INC
BGC
Rubric Capital Management LP16,972,580
4.500%
-3,027,420decrease
(-15.14%)
View
2024-11-13
4:30 pm
Purchase
13GDOLE PLC SHS
DOLE
Rubric Capital Management LP5,141,388
5.410%
5,141,388increase
(New Position)
View
2024-11-13
4:30 pm
Sale
13GCOLLEGIUM PHARMACEUTICAL INC C
COLL
Rubric Capital Management LP1,250,000
3.880%
-1,508,253decrease
(-54.68%)
View
2024-11-13
4:30 pm
Sale
13GGoodRx Holdings Inc.
GDRX
Rubric Capital Management LP4,680,028
4.750%
-1,192,778decrease
(-20.31%)
View
2024-11-13
4:30 pm
Sale
13GWEREWOLF THERAPEUTICS INC
HOWL
Rubric Capital Management LP1,333,893
3.050%
-601,464decrease
(-31.08%)
View
2024-11-13
4:30 pm
Purchase
13GSTRATASYS LTD.
SSYS
Rubric Capital Management LP6,191,000
8.670%
1,941,000increase
(+45.67%)
View
2024-11-13
4:30 pm
Purchase
13GPediatrix Medical Group Inc.
MD
Rubric Capital Management LP8,275,000
9.640%
8,275,000increase
(New Position)
View
2024-11-13
4:30 pm
Purchase
13GOPKO HEALTH INC.
OPK
Rubric Capital Management LP48,706,640
6.980%
48,706,640increase
(New Position)
View
2024-11-13
4:30 pm
Purchase
13GQuidelOrtho Corp
QDEL
Rubric Capital Management LP4,200,000
6.250%
4,200,000increase
(New Position)
View
2024-11-13
4:30 pm
Purchase
13GReNew Energy Global plc
RNW
Rubric Capital Management LP13,706,102
5.610%
13,706,102increase
(New Position)
View
2024-11-13
4:30 pm
Sale
13GTrevi Therapeutics Inc.
TRVI
Rubric Capital Management LP5,026,931
6.920%
-657,489decrease
(-11.57%)
View
Goto 0, 1, 2, ...5, 6, Next